The Physiological Functions of Iron Regulatory Proteins in Iron Homeostasis - an Update

Overview

Journal Front Pharmacol

Date 2014 Jul 2

PMID 24982634

Citations 128

Authors

De-Liang Zhang

Manik C Ghosh

Tracey A Rouault

Affiliations

Soon will be listed here.

Abstract

Iron regulatory proteins (IRPs) regulate the expression of genes involved in iron metabolism by binding to RNA stem-loop structures known as iron responsive elements (IREs) in target mRNAs. IRP binding inhibits the translation of mRNAs that contain an IRE in the 5'untranslated region of the transcripts, and increases the stability of mRNAs that contain IREs in the 3'untranslated region of transcripts. By these mechanisms, IRPs increase cellular iron absorption and decrease storage and export of iron to maintain an optimal intracellular iron balance. There are two members of the mammalian IRP protein family, IRP1 and IRP2, and they have redundant functions as evidenced by the embryonic lethality of the mice that completely lack IRP expression (Irp1 (-/-)/Irp2(-/-) mice), which contrasts with the fact that Irp1 (-/-) and Irp2 (-/-) mice are viable. In addition, Irp2 (-/-) mice also display neurodegenerative symptoms and microcytic hypochromic anemia, suggesting that IRP2 function predominates in the nervous system and erythropoietic homeostasis. Though the physiological significance of IRP1 had been unclear since Irp1 (-/-) animals were first assessed in the early 1990s, recent studies indicate that IRP1 plays an essential function in orchestrating the balance between erythropoiesis and bodily iron homeostasis. Additionally, Irp1 (-/-) mice develop pulmonary hypertension, and they experience sudden death when maintained on an iron-deficient diet, indicating that IRP1 has a critical role in the pulmonary and cardiovascular systems. This review summarizes recent progress that has been made in understanding the physiological roles of IRP1 and IRP2, and further discusses the implications for clinical research on patients with idiopathic polycythemia, pulmonary hypertension, and neurodegeneration.

Citing Articles

Preventing and Managing Pre- and Postoperative Micronutrient Deficiencies: A Vital Component of Long-Term Success in Bariatric Surgery.

Reytor-Gonzalez C, Frias-Toral E, Nunez-Vasquez C, Parise-Vasco J, Zambrano-Villacres R, Simancas-Racines D Nutrients. 2025; 17(5).

PMID: 40077612 PMC: 11902093. DOI: 10.3390/nu17050741.

Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases.

Wu K, Zhao W, Hou Z, Zhang W, Qin L, Qiu J Front Cell Dev Biol. 2025; 13:1551003.

PMID: 40070880 PMC: 11893559. DOI: 10.3389/fcell.2025.1551003.

Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer's Disease.

Khan M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770511 PMC: 11677800. DOI: 10.3390/ph17121669.

Enhanced CRC Growth in Iron-Rich Environment, Facts and Speculations.

Chieppa M, Kashyrina M, Miraglia A, Vardanyan D Int J Mol Sci. 2024; 25(22).

PMID: 39596454 PMC: 11594836. DOI: 10.3390/ijms252212389.

Effects of iron overload in human joint tissue explant cultures and animal models.

Prasadam I, Schrobback K, Kranz-Rudolph B, Fischer N, Sonar Y, Sun A J Mol Med (Berl). 2024; 103(1):73-86.

PMID: 39531048 DOI: 10.1007/s00109-024-02495-9.

References

Rouault T . Cell biology. An ancient gauge for iron. Science. 2009; 326(5953):676-7. PMC: 2932448. DOI: 10.1126/science.1181938. View

Iacovelli J, Mlodnicka A, Veldman P, Ying G, Dunaief J, Schumacher A . Brain and retinal ferroportin 1 dysregulation in polycythaemia mice. Brain Res. 2009; 1289:85-95. PMC: 2736625. DOI: 10.1016/j.brainres.2009.06.098. View

Hickey M, Lam J, Bezman N, Rathmell W, Simon M . von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. J Clin Invest. 2007; 117(12):3879-89. PMC: 2066197. DOI: 10.1172/JCI32614. View

Mok H, Mendoza M, Prchal J, Balogh P, Schumacher A . Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice. Development. 2004; 131(19):4871-81. DOI: 10.1242/dev.01342. View

Ganz T, Nemeth E . Hepcidin and disorders of iron metabolism. Annu Rev Med. 2010; 62:347-60. DOI: 10.1146/annurev-med-050109-142444. View

Garrick M, Dolan K, Horbinski C, Ghio A, Higgins D, Porubcin M . DMT1: a mammalian transporter for multiple metals. Biometals. 2003; 16(1):41-54. DOI: 10.1023/a:1020702213099. View

Wallander M, Leibold E, Eisenstein R . Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta. 2006; 1763(7):668-89. PMC: 2291536. DOI: 10.1016/j.bbamcr.2006.05.004. View

Jeong S, Crooks D, Wilson-Ollivierre H, Ghosh M, Sougrat R, Lee J . Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS One. 2011; 6(10):e25404. PMC: 3189198. DOI: 10.1371/journal.pone.0025404. View

Ye H, Rouault T . Erythropoiesis and iron sulfur cluster biogenesis. Adv Hematol. 2010; 2010. PMC: 2939393. DOI: 10.1155/2010/329394. View

10.

Casarrubea D, Viatte L, Hallas T, Vasanthakumar A, Eisenstein R, Schumann K . Abnormal body iron distribution and erythropoiesis in a novel mouse model with inducible gain of iron regulatory protein (IRP)-1 function. J Mol Med (Berl). 2013; 91(7):871-81. PMC: 3695688. DOI: 10.1007/s00109-013-1008-2. View

11.

Wingert R, Galloway J, Barut B, Foott H, Fraenkel P, Axe J . Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005; 436(7053):1035-39. DOI: 10.1038/nature03887. View

12.

Henderson B, Seiser C, Kuhn L . Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements. J Biol Chem. 1993; 268(36):27327-34. View

13.

Ye H, Jeong S, Ghosh M, Kovtunovych G, Silvestri L, Ortillo D . Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest. 2010; 120(5):1749-61. PMC: 2860907. DOI: 10.1172/JCI40372. View

14.

Ohgami R, Campagna D, Greer E, Antiochos B, McDonald A, Chen J . Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005; 37(11):1264-9. PMC: 2156108. DOI: 10.1038/ng1658. View

15.

Gordeuk V, Prchal J . Vascular complications in Chuvash polycythemia. Semin Thromb Hemost. 2006; 32(3):289-94. DOI: 10.1055/s-2006-939441. View

16.

Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt S, Moynihan J . Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000; 403(6771):776-81. DOI: 10.1038/35001596. View

17.

Ferring-Appel D, Hentze M, Galy B . Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism. Blood. 2008; 113(3):679-87. DOI: 10.1182/blood-2008-05-155093. View

18.

Pawlus M, Hu C . Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response. Cell Signal. 2013; 25(9):1895-903. PMC: 3700616. DOI: 10.1016/j.cellsig.2013.05.018. View

19.

Ghosh M, Tong W, Zhang D, Ollivierre-Wilson H, Singh A, Krishna M . Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice. Proc Natl Acad Sci U S A. 2008; 105(33):12028-33. PMC: 2497459. DOI: 10.1073/pnas.0805361105. View

20.

Moroishi T, Nishiyama M, Takeda Y, Iwai K, Nakayama K . The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. Cell Metab. 2011; 14(3):339-51. DOI: 10.1016/j.cmet.2011.07.011. View